DE69526434T2 - Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung - Google Patents

Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung

Info

Publication number
DE69526434T2
DE69526434T2 DE69526434T DE69526434T DE69526434T2 DE 69526434 T2 DE69526434 T2 DE 69526434T2 DE 69526434 T DE69526434 T DE 69526434T DE 69526434 T DE69526434 T DE 69526434T DE 69526434 T2 DE69526434 T2 DE 69526434T2
Authority
DE
Germany
Prior art keywords
metronidazole
aqueous
aqueous soluble
compositions
diluent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69526434T
Other languages
English (en)
Other versions
DE69526434D1 (de
Inventor
Subhash Desai
Alan Mark Mancini
Steven Charles Schumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of DE69526434D1 publication Critical patent/DE69526434D1/de
Application granted granted Critical
Publication of DE69526434T2 publication Critical patent/DE69526434T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69526434T 1994-01-27 1995-01-04 Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung Expired - Fee Related DE69526434T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/187,568 US6103262A (en) 1994-01-27 1994-01-27 Modified-release metronidazole compositions and methods for making and using same
PCT/US1995/000005 WO1995020383A1 (en) 1994-01-27 1995-01-04 Modified-release metronidazole compositions and methods for making and using same

Publications (2)

Publication Number Publication Date
DE69526434D1 DE69526434D1 (de) 2002-05-23
DE69526434T2 true DE69526434T2 (de) 2002-10-31

Family

ID=22689500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526434T Expired - Fee Related DE69526434T2 (de) 1994-01-27 1995-01-04 Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung

Country Status (16)

Country Link
US (2) US6103262A (de)
EP (1) EP0744947B1 (de)
JP (1) JPH09508381A (de)
KR (1) KR100368769B1 (de)
CN (1) CN1095665C (de)
AT (1) ATE216236T1 (de)
AU (1) AU682248B2 (de)
BR (1) BR9506662A (de)
CA (1) CA2181985C (de)
DE (1) DE69526434T2 (de)
DK (1) DK0744947T3 (de)
ES (1) ES2174930T3 (de)
MX (1) MX9602951A (de)
NZ (1) NZ279368A (de)
PT (1) PT744947E (de)
WO (1) WO1995020383A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8588898A (en) 1997-07-28 1999-02-16 Mary L. Redmond Composition and process for the treatment of epidermal traumas such as decubitusulcers
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
ECSP003851A (es) * 1999-12-22 2002-05-23 Pharmacia Corp Composicon de liberacion doble de un inhibidor ciclooxigenasa-2
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
US8846100B2 (en) * 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
WO2012075015A2 (en) 2010-11-29 2012-06-07 Dr. Reddy's Laboratories Ltd. Oral metronidazole pharmaceutical compositions
WO2013111070A1 (en) * 2012-01-23 2013-08-01 Ranbaxy Laboratories Limited In-situ multilayered tablet technology
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
CA2988082C (en) * 2015-06-01 2020-09-29 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
WO2017027528A1 (en) * 2015-08-10 2017-02-16 Purdue Research Foundation Methods and systems for depositing active ingredients on substrates
GR1008992B (el) 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
CN112007002B (zh) * 2020-08-05 2022-08-12 河北君临药业有限公司 一种质量稳定的甲硝唑片剂组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944061A (en) * 1957-09-20 1960-07-05 Acyl derivatives and process
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
DE4125048A1 (de) * 1991-07-29 1993-02-04 Peggy Albrecht Arzneimittel mit verzoegerter freisetzung zur behandlung von periodontitis
CA2093282C (en) * 1992-05-04 1999-01-12 Tibor Sipos Intraoral medicament-releasing device

Also Published As

Publication number Publication date
MX9602951A (es) 1997-06-28
WO1995020383A1 (en) 1995-08-03
CA2181985A1 (en) 1995-08-03
US5618559A (en) 1997-04-08
CN1139382A (zh) 1997-01-01
CA2181985C (en) 2000-12-05
NZ279368A (en) 1998-04-27
JPH09508381A (ja) 1997-08-26
ATE216236T1 (de) 2002-05-15
AU1596795A (en) 1995-08-15
EP0744947A1 (de) 1996-12-04
CN1095665C (zh) 2002-12-11
ES2174930T3 (es) 2002-11-16
PT744947E (pt) 2002-08-30
AU682248B2 (en) 1997-09-25
BR9506662A (pt) 1997-11-18
KR100368769B1 (ko) 2003-05-16
DE69526434D1 (de) 2002-05-23
DK0744947T3 (da) 2002-07-29
EP0744947B1 (de) 2002-04-17
US6103262A (en) 2000-08-15

Similar Documents

Publication Publication Date Title
DE69526434T2 (de) Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
ATE219499T1 (de) Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung
MXPA04011914A (es) Formulacion farmaceutica de liberacion modificada.
DE69726457D1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
IL112020A0 (en) Arylacetic acid derivatives, their preparation and their use as fungicides
ATE137753T1 (de) Codeinsalz einer substituierten carbonsäure, verfahren zu seiner herstellung, seine verwendung und pharmazeutische präparate
ATE164578T1 (de) Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten
EP0400522A3 (de) Verfahren zur Herstellung mikronisierter bioabbaubarer Partikel
DE60002126D1 (de) Substituierte dimere Carboxamid-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
WO2002028821A3 (de) Propionsäurederivate mit ppar-alpha aktivierenden eigenschaften.
DE69027221D1 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
DE69410614D1 (de) Bis-naphthalimide für die behandlung von krebs
DE69420832T2 (de) Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8
DE69517191D1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
FI954786A0 (fi) Menetelmä aminometaanifosfonihapon valmistamiseksi
ATE112276T1 (de) Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
IT1273455B (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
ATE145205T1 (de) Dithiansubstituierte propenale und verfahren zu ihrer herstellung
ATE204872T1 (de) Verfahren zur herstellung von anhydroecgonin- estern
DE59106666D1 (de) Bicyclo [3.3.0]octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
EP0390066A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0310909A3 (de) Heteroanellierte Phenylglycin-beta-Lactam-Antibiotika, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ES2079997A1 (es) Compuestos de fenil fenol sustituidos antagonistas de leucotrieno, procedimiento para su obtencion y formulaciones farmaceuticas de los mismos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee